These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 20060709

  • 1. Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients.
    Bignotti E, Todeschini P, Calza S, Falchetti M, Ravanini M, Tassi RA, Ravaggi A, Bandiera E, Romani C, Zanotti L, Tognon G, Odicino FE, Facchetti F, Pecorelli S, Santin AD.
    Eur J Cancer; 2010 Mar; 46(5):944-53. PubMed ID: 20060709
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of mammaglobin B in epithelial ovarian carcinomas.
    Tassi RA, Bignotti E, Rossi E, Falchetti M, Donzelli C, Calza S, Ravaggi A, Bandiera E, Pecorelli S, Santin AD.
    Gynecol Oncol; 2007 Jun; 105(3):578-85. PubMed ID: 17343903
    [Abstract] [Full Text] [Related]

  • 3. Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy.
    Bignotti E, Tassi RA, Calza S, Ravaggi A, Romani C, Rossi E, Falchetti M, Odicino FE, Pecorelli S, Santin AD.
    Gynecol Oncol; 2006 Nov; 103(2):405-16. PubMed ID: 16725184
    [Abstract] [Full Text] [Related]

  • 4. [Relationship between expressions of p53, c-erbB2 genes, proliferating cell nuclear antigen and prognosis of patients with ovarian epithelial carcinoma].
    Li JD, Li MD, Li YF, Huang X, Liu JH, Liu FY, Zhang CQ.
    Ai Zheng; 2002 Mar; 21(3):292-6. PubMed ID: 12451998
    [Abstract] [Full Text] [Related]

  • 5. [Correlation of DPPIV expression with clinicopathological features and prognosis in epithelial ovarian carcinoma].
    Zhang MZ, Qiao YH, Suo ZH.
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):848-52. PubMed ID: 19173831
    [Abstract] [Full Text] [Related]

  • 6. Expression of MUC1 in primary and metastatic human epithelial ovarian cancer and its therapeutic significance.
    Wang L, Ma J, Liu F, Yu Q, Chu G, Perkins AC, Li Y.
    Gynecol Oncol; 2007 Jun; 105(3):695-702. PubMed ID: 17368732
    [Abstract] [Full Text] [Related]

  • 7. Expression and prognostic significance of PDCD4 in human epithelial ovarian carcinoma.
    Wang X, Wei Z, Gao F, Zhang X, Zhou C, Zhu F, Wang Q, Gao Q, Ma C, Sun W, Kong B, Zhang L.
    Anticancer Res; 2008 Jun; 28(5B):2991-6. PubMed ID: 19031945
    [Abstract] [Full Text] [Related]

  • 8. Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer.
    Bali A, O'Brien PM, Edwards LS, Sutherland RL, Hacker NF, Henshall SM.
    Clin Cancer Res; 2004 Aug 01; 10(15):5168-77. PubMed ID: 15297421
    [Abstract] [Full Text] [Related]

  • 9. A-kinase anchoring protein 3 messenger RNA expression correlates with poor prognosis in epithelial ovarian cancer.
    Sharma S, Qian F, Keitz B, Driscoll D, Scanlan MJ, Skipper J, Rodabaugh K, Lele S, Old LJ, Odunsi K.
    Gynecol Oncol; 2005 Oct 01; 99(1):183-8. PubMed ID: 16005946
    [Abstract] [Full Text] [Related]

  • 10. Expression and amplification of eIF-5A2 in human epithelial ovarian tumors and overexpression of EIF-5A2 is a new independent predictor of outcome in patients with ovarian carcinoma.
    Yang GF, Xie D, Liu JH, Luo JH, Li LJ, Hua WF, Wu HM, Kung HF, Zeng YX, Guan XY.
    Gynecol Oncol; 2009 Feb 01; 112(2):314-8. PubMed ID: 19054548
    [Abstract] [Full Text] [Related]

  • 11. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker.
    Yousef GM, Kyriakopoulou LG, Scorilas A, Fracchioli S, Ghiringhello B, Zarghooni M, Chang A, Diamandis M, Giardina G, Hartwick WJ, Richiardi G, Massobrio M, Diamandis EP, Katsaros D.
    Cancer Res; 2001 Nov 01; 61(21):7811-8. PubMed ID: 11691797
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer.
    Shigemasa K, Tian X, Gu L, Tanimoto H, Underwood LJ, O'Brien TJ, Ohama K.
    Oncol Rep; 2004 Jun 01; 11(6):1153-9. PubMed ID: 15138549
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK, Kacinski BM, Ivins CM, Carcangiu ML.
    Clin Cancer Res; 1997 Jun 01; 3(6):999-1007. PubMed ID: 9815777
    [Abstract] [Full Text] [Related]

  • 15. [Expression of p21(WAF1) and its relationship with p53 and PCNA protein in epithelial ovarian cancer].
    Yan XJ, Liang LZ, Li DC, Li JL, Zhang CQ, Yuan SH.
    Ai Zheng; 2004 Jan 01; 23(1):74-80. PubMed ID: 14720380
    [Abstract] [Full Text] [Related]

  • 16. PEA3 is the second Ets family transcription factor involved in tumor progression in ovarian carcinoma.
    Davidson B, Goldberg I, Gotlieb WH, Kopolovic J, Ben-Baruch G, Reich R.
    Clin Cancer Res; 2003 Apr 01; 9(4):1412-9. PubMed ID: 12684413
    [Abstract] [Full Text] [Related]

  • 17. Skp2 overexpression is a prognostic factor in patients with ovarian adenocarcinoma.
    Shigemasa K, Gu L, O'Brien TJ, Ohama K.
    Clin Cancer Res; 2003 May 01; 9(5):1756-63. PubMed ID: 12738731
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma.
    Xu N, Zhang Z, Zhu J, Xu L, Li Y, Duan L, Mao Y, Li H.
    Int J Exp Pathol; 2016 Apr 01; 97(2):150-8. PubMed ID: 27127000
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma.
    Davidson B, Reich R, Goldberg I, Gotlieb WH, Kopolovic J, Berner A, Ben-Baruch G, Bryne M, Nesland JM.
    Clin Cancer Res; 2001 Mar 01; 7(3):551-7. PubMed ID: 11297247
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.